Over 500 Leaders from Across More Than 50 Countries and Territories Attend 56th Annual World Trade Centers Association Global Business Forum in Philadelphia
Flagship WTCA event delivers high-impact sector insights and global business connections across industries NEW YORK, May 12, 2026 /PRNewswire/ -- World Trade Centers Association® (WTCA®) — an international trade organization connecting more than 300...
Next Level Aviation® Appoints Clive Rankin as Senior Vice President - Global Business Development
DANIA BEACH, Fla., May 12, 2026 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in the global distribution of used serviceable materials (USM) for all Boeing and Airbus commercial aircraft and associated jet engine platforms, has appointed...
EquiLend Acquires Finadium, Expanding Presence in Securities Finance Research & Consulting
Finadium to continue operating independently as a subsidiary of EquiLend NEW YORK, May 12, 2026 /PRNewswire/ -- EquiLend, a global leader in securities finance technology, data, and analytics, today announced the acquisition of Finadium, a premier...
Liene Mother's Day Campaign Breaks Out with 2 Million Views, Redefining Women's Multi-Dimensional Identities
The campaign redefined Mother's Day celebration from one-way gratitude to seeing and connecting with the whole individual LOS ANGELES, May 12, 2026 /PRNewswire/ -- Liene, a global leader in smart printing solutions, today announced the successful...
Getac to Showcase Rugged Devices and Integrated Tactical Solutions at SOF Week 2026
AI-enabled platforms designed to support secure communications and mission execution in challenging environments IRVINE, Calif., May 12, 2026 /PRNewswire/ -- Getac Technology Corporation ("Getac"), a leading provider of rugged computing and mobile...
Halia Therapeutics to Present Final Phase 2 Ofirnoflast Data in Lower-Risk MDS at EHA2026 and Announces Appointment of Han Myint, MD, FACP, as Chief Medical Officer
European Hematology Association (EHA) oral presentation to report 67% hematological improvement, durable transfusion independence, and no treatment-related serious adverse events in ESA-refractory lower-risk MDS Dr. Myint, a hematology leader and...
Insilico Medicine and Ribo Enter Strategic Collaboration Agreement: Leveraging AI Platform and Automated Lab for End-to-End Empowerment of RNA Interference and Oligonucleotide Therapeutics Development
SHANGHAI, May 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has entered a strategic collaboration agreement with Suzhou Ribo...
Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
SUZHOU, China, May 12, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ("Ribo", 06938.HK) announced that the Company has entered into a strategic collaboration agreement with Insilico Medicine ("Insilico", 03696.HK). Both parties will...